Evidence map›Paper›PMID 14610293›Full record

ReviewEndocrine2003

Regulation of ghrelin secretion and action.

Jesus P Camiña, Marcos C Carreira, Dragan Micic, Manuel Pombo, Fahrettin Kelestimur, Carlos Dieguez, Felipe F Casanueva

Abstract readReview
PubMed Publisher
In one paragraph

Review in Endocrine, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 58 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Regulation and roles of Ca2+ stores in human sperm.Reproduction (Cambridge, England) · 2015
    Review
  8. Article
  9. Ghrelin: ghrelin as a regulatory Peptide in growth hormone secretion.Journal of clinical and diagnostic research : JCDR · 2014
    Review
  10. Ghrelin and the central regulation of feeding and energy balance.Indian journal of endocrinology and metabolism · 2012
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 4 countries.

Jesus P CamiñaDepartment of Medicine, Research Area, Molecular Endocrinology Laboratory, School of Medicine and Complejo Hospitalario Universitario de Santiago, University of Santiago de Compostela, E-15780 Santiago de Compostela, Spain.
Marcos C Carreira
Dragan Micic
Manuel Pombo
Fahrettin Kelestimur
Carlos Dieguez
Felipe F Casanueva
Universidade de Santiago de Compostela · ESComplejo Hospitalario Universitario de Santiago · ESKayseri Eğitim ve Araştırma Hastanesi · TRUniversity Clinical Centre · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The pulsatile release of growth hormone (GH) from anterior pituitary gland is regulated by the interplay of at least two hypothalamic hormones, GH-releasing hormone (GHRH) and somatostatin, via their engagement with specific cell surface receptors on the anterior pituitary somatotroph. Furthermore, release of GH in vivo may also be controlled by a third type of receptor, the growth hormone secretagogue receptor, a G-protein-coupled receptor, called GHS receptor type 1a (GHSR1a), which was identified in the pituitary and the hypothalamus in humans using a nonpeptidyl growth hormone secretagogue (MK-0677). Ghrelin, the endogenous ligand for the GHS-R1a, is a 28-amino-acid peptide isolated from human stomach that is modified by a straight chain octanoyl group covalently linked to Ser3, which is essential for its endocrine activity. This hormone, predominantly expressed and secreted by the stomach, has a dual action on GH secretion and food intake, showing interdependency between these actions. The finding that fasting and food intake, respectively, increase and decrease the secretion of ghrelin suggests that this hormone may be the bridge connecting somatic growth and body composition with energy metabolism, and appears to play a role in the alteration of energy homeostasis and body weight in pathophysiological states such as hypothyroidism and hyperthyroidism. Despite this, little is known about the intracellular signaling through which ghrelin exerts its regulatory actions. Activation of intracellular calcium mobilization is one of the earliest known cellular signals elicited by ghrelin. In HEK- 293 cells expressing the GHS-R1a, ghrelin induces a biphasic cytosolic calcium elevation characterized by a spike phase of the response, which reflects Ins(1,4,5)P3- dependent calcium mobilization of intracellular stores, and a sustained phase of the response, which is due to calcium influx across the plasma membrane triggered by aperture of capacitative calcium channels (store-operated calcium channels). Upon repeated administration, ghrelin showed a marked suppression of ghrelin-mediated elevations of intracellular calcium. This homologous desensitization represents an important physiological mechanism that modulates receptor responsiveness and acts as an information filter for intracellular signaling system. The discovery of ghrelin adds a new component to the complex machinery responsible for regulation of GH secretion in connection with the regulation of appetite and energy homeostasis.

Indexed as

AnimalsGhrelinHomeostasisHuman Growth HormoneHumansPeptide HormonesReceptors, GhrelinReceptors, G-Protein-CoupledSecond Messenger SystemsSignal TransductionGhrelinHuman Growth HormonePeptide HormonesReceptors, GhrelinReceptors, G-Protein-Coupled

Identifiers

PMID14610293
OpenAlexW2006425264

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.